long
rtpcr
lrp
amplif
rna
templat
sometim
difficult
compar
long
pcr
dna
templat
among
rna
templat
hepat
c
viru
hcv
repres
excel
exampl
challeng
potenti
lrp
technolog
due
extens
secondari
structur
difficulti
readili
cultur
vitro
sourc
viral
genom
amplif
clinic
sampl
hcv
usual
present
low
titer
creat
comprehens
optim
protocol
allow
robust
amplif
kb
fragment
hcv
follow
effici
clone
novel
vector
detail
analys
indic
lack
potenti
lrpmediat
recombin
preserv
viral
divers
thu
lrp
protocol
could
appli
amplif
difficult
rna
templat
may
facilit
rna
viru
research
link
viral
mutat
revers
genet
bbrc
protocol
effici
amplif
clone
near
fulllength
hcv
genom
clinic
sampl
also
estim
sensit
potenti
pcrmediat
recombin
relat
protocol
polymeras
chain
reaction
pcr
indispens
techniqu
biomed
research
known
primer
sequenc
easili
amplifi
dna
target
less
kb
diminish
power
target
larger
kb
barn
et
al
first
hypothes
inabl
amplifi
larg
dna
fragment
due
misincorpor
nucleotid
thermost
dna
polymeras
result
prematur
termin
pcr
base
hypothesi
mix
polymeras
one
exonucleas
proofread
activ
correct
misincorpor
success
amplifi
dna
target
kb
howev
limit
success
appli
concept
amplif
larg
rna
genom
requir
revers
transcript
rt
step
prior
pcr
amplif
compar
amplif
dna
target
reason
hypothes
rt
step
crucial
import
long
rtpcr
lrp
perform
take
account
follow
characterist
first
situat
solut
buffer
compat
rt
pcr
part
rt
reaction
use
subsequ
pcr
thu
reduc
sensit
dramat
second
rt
enzym
inhibitori
role
thermost
dna
polymeras
third
rt
conduct
temperatur
rang
rna
templat
may
retain
secondari
structur
make
rt
stop
prematur
situat
even
challeng
tri
amplifi
fulllength
hepat
c
viru
hcv
genom
posit
sens
singlestrand
rna
viru
famili
flavirivida
extens
secondari
structur
along
whole
hcv
genom
furthermor
hcv
cultur
vitro
sourc
rna
templat
lrp
clinic
sampl
hcv
low
titer
present
studi
investig
step
lrp
procedur
develop
robust
sampl
lrp
optim
directli
conduct
serum
sampl
collect
two
patient
infect
hcv
genotyp
refer
rj
respect
larg
volum
serum
store
avail
two
patient
allow
repeat
detail
optim
lrp
protocol
optim
addit
serum
sampl
use
estim
sensit
robust
potenti
recombin
see
hcv
rna
level
quantit
bdna
assay
bayer
versant
hcv
immedi
prior
start
studi
rna
extract
total
rna
extract
serum
use
either
qiaamp
viral
rna
mini
kit
qiagen
valencia
ca
trizol
ls
reagent
invitrogen
carlsbad
ca
accord
instruct
provid
qiaamp
viral
rna
mini
kit
rna
extract
serum
final
elut
tri
buffer
contain
uml
rnasein
ribonucleas
inhibitor
promega
madison
wi
extract
trizol
ls
reagent
serum
appli
rna
pellet
final
dissolv
nucleasefre
water
contain
uml
rnasein
ribonucleas
inhibitor
promega
addit
either
glycogen
invitrogen
transfer
rna
trna
sigma
st
loui
mo
use
facilit
rna
precipit
method
vigor
vortex
avoid
prevent
shear
long
rna
templat
revers
transcript
sinc
rt
critic
step
success
lrp
optim
step
follow
first
test
multipl
rt
enzym
alon
combin
includ
amv
promega
mmlv
promega
expand
revers
transcriptas
roch
appli
scienc
indianapoli
transcriptor
revers
transcriptas
roch
appli
scienc
superscript
ii
invitrogen
superscript
iii
invitrogen
rtth
dna
polymeras
appli
biosystem
foster
citi
ca
show
revers
transcriptas
activ
presenc
mncl
elev
temperatur
experi
mix
rt
enzym
pfu
dna
polymeras
stratagen
similar
strategi
use
long
pcr
improv
fulllength
cdna
synthesi
second
previou
studi
show
certain
chemic
might
improv
fulllength
cdna
synthesi
quantiti
qualiti
studi
tri
differ
addit
variou
concentr
includ
dmso
sigma
gcmelt
bd
bioscienc
dtt
mm
trehalos
sigma
betain
sigma
third
design
seri
hcvspecif
rt
primer
locat
end
tabl
primer
test
effici
prime
differ
concentr
fourth
besid
direct
applic
rt
reaction
subsequ
pcr
also
tri
purifi
rt
reaction
without
rnase
h
digest
prior
pcr
use
qiaquick
pcr
purif
kit
qiaquick
nucleotid
remov
kit
qiagen
dynabead
kilobasebind
kit
dynal
rt
primer
biotinyl
end
final
also
investig
role
deoxyguanosin
sigma
rt
reaction
may
improv
elong
gcrich
domain
pcr
pcr
experi
done
dna
thermal
cycler
perkinelmercetu
norwalk
ct
nest
pcr
strategi
touchdown
protocol
gener
appli
begin
test
sever
thermost
dna
polymeras
long
pcr
expand
long
templat
pcr
system
roch
appli
scienc
elongas
enzym
mix
invitrogen
eventu
focus
rtth
dna
polymeras
xl
appli
biosystem
foster
citi
ca
optim
experi
done
enzym
strategi
optim
long
pcr
basic
similar
describ
rt
step
multipl
addit
first
test
includ
dmso
betain
tetramethylammonium
tma
oxal
next
seri
primer
test
effici
long
pcr
tabl
meantim
sinc
one
mix
polymeras
exonucleas
proofread
activ
may
degrad
primer
test
phosphorothio
primer
see
pcr
amplif
improv
allow
hotstart
pcr
may
diminish
nonspecif
prime
adopt
two
measur
use
loop
incorpor
primer
oligonucleotid
special
inhibit
dna
polymeras
isol
thermu
thermophilu
tth
pol
low
temperatur
final
dna
thermal
cycler
empir
fix
denatur
temperatur
elong
temperatur
min
anneal
step
howev
anneal
temperatur
adjust
depend
valu
primer
tabl
molecular
clone
hcv
envelop
domain
hcv
display
typic
quasispeci
natur
share
rna
virus
understand
lrp
protocol
conserv
viral
divers
compar
hcv
quasispeci
profil
deriv
regular
rtpcr
lrp
product
two
patient
sampl
viral
heterogen
detail
two
patient
previou
studi
base
kb
amplicon
span
hypervari
region
hcv
genom
brief
serum
rna
revers
transcrib
u
mmlv
revers
transcriptas
promega
follow
nest
pcr
taq
dna
polymeras
appli
biosystem
pcr
product
gel
purifi
use
qiaex
ii
gel
extract
kit
qiagen
ligat
ptopota
clone
vector
invitrogen
escherichia
coli
cell
invitrogen
use
transform
recoveri
recombin
clone
approxim
clone
sampl
sequenc
abi
prism
dye
termin
cycl
sequenc
readi
reaction
kit
use
abi
autom
sequenc
appli
biosystem
molecular
clone
long
rtpcr
product
clone
lrp
product
first
tri
sever
commerci
clone
kit
includ
topo
xl
pcr
clone
kit
invitrogen
copylight
clone
kit
clone
smart
blunt
clone
kit
lucigen
corpor
middleton
wi
without
success
next
estim
clone
effici
gateway
technolog
clonas
ii
invitrogen
final
return
convent
clone
strategi
lrp
product
digest
two
restrict
enzym
paci
fsei
follow
ligat
special
plasmid
name
pclone
ligat
product
electropor
cell
cell
invitrogen
pclone
vector
construct
replac
pacibamhi
fragment
padtrackcmv
bp
fragment
assembl
includ
rare
restrict
enzym
found
hcv
genom
base
analysi
fulllength
hcv
genotyp
isol
posit
recombin
clone
identifi
either
digest
partial
sequenc
end
insert
estim
pcrmediat
recombin
pcr
may
induc
homolog
recombin
rate
recombin
depend
protocol
use
optim
long
rtpcr
estim
potenti
recombin
relat
protocol
sera
sampl
mix
equal
amount
follow
procedur
rna
extract
rt
long
pcr
clone
approxim
posit
recombin
clone
sequenc
domain
locat
within
utr
core
region
respect
recombin
would
indic
given
clone
conflict
cluster
note
phylogenet
tree
construct
domain
sequenc
genet
analysi
sequenc
align
clustal
w
version
sequenc
edit
multipl
sequenc
comparison
perform
match
program
wisconsin
gcg
packag
oxford
molecular
group
inc
version
mean
genet
distanc
number
synonym
substitut
per
synonym
site
ds
number
nonsynonym
substitut
per
nonsynonym
site
dn
calcul
kimura
method
site
molecular
evolutionari
genet
analysi
softwar
packag
mega
version
phylogenet
tree
construct
use
neighborjoin
method
bootstrap
test
implant
mega
genet
complex
nucleotid
amino
acid
level
evalu
respect
sampl
calcul
normal
entropi
n
n
slnn
n
total
number
clone
p
pi
ln
pi
pi
frequenc
clone
viral
quasispeci
popul
statist
test
student
ttest
use
analyz
differ
mean
valu
genet
paramet
data
normal
distribut
nonparametr
test
use
evalu
sampl
normal
distribut
present
synthesi
fulllength
hcv
cdna
prerequisit
success
lrp
sever
group
perform
nest
pcr
hcv
utr
rt
step
assum
posit
result
indic
fulllength
hcv
cdna
synthesi
howev
found
multipl
domain
locat
within
utr
core
respect
could
success
amplifi
rt
rt
primer
omit
indic
exist
extens
selfprim
rt
presum
induc
hcv
rna
secondari
structur
oligonucleotid
extract
rna
templat
use
dna
thermal
cycler
whole
procedur
lrp
take
least
day
therefor
amplifi
multipl
small
fragment
utr
tabl
use
first
round
lrp
product
templat
first
round
lrp
effect
selfprim
reduc
neg
amplif
small
fragment
indic
absolut
absenc
fulllength
hcv
cdna
thu
second
round
lrp
necessari
test
lrp
condit
paramet
alon
combin
optim
procedur
consist
hundr
protocol
approach
monitor
fulllength
cdna
synthesi
base
first
round
pcr
product
although
perfect
still
improv
experiment
progress
significantli
two
rna
extract
procedur
base
either
qiaamp
viral
rna
mini
kit
qiagen
trizol
ls
reagent
invitrogen
gave
similar
lrp
result
howev
latter
procedur
addit
trna
glycogen
rna
precipit
even
low
concentr
result
failur
subsequ
pcr
suggest
carrier
detriment
role
rtth
xl
activ
optim
rt
summar
follow
superscript
iii
outperform
revers
transcriptas
amv
mmlv
expand
revers
transcriptas
transcriptor
revers
transcriptas
superscript
ii
rtth
dna
polymeras
robust
lrp
result
obtain
run
rt
u
superscript
iii
min
follow
inactiv
min
howev
use
mixtur
superscript
iii
u
amv
u
gave
lrp
result
much
reproduc
increas
yield
lrp
success
use
mixtur
rt
enzym
pfu
dna
polymeras
perhap
latter
low
activ
nonoptim
buffer
system
rt
temperatur
stratagen
person
commun
addit
except
dtt
test
rt
reaction
advers
role
lrp
although
addit
report
improv
fulllength
cdna
synthesi
may
compat
superscript
iii
rtth
xl
dna
polymeras
select
rt
primer
critic
success
lrp
satisfactori
reproduc
result
obtain
use
rt
primer
tabl
interestingli
lrp
work
replac
suggest
appropri
valu
rt
primer
requir
howev
lrp
fail
modifi
rt
primer
similar
valu
contrast
reproduc
amplif
obtain
serum
sampl
one
two
nucleotid
substitut
observ
suggest
effici
prime
fulllength
hcv
cdna
synthesi
domaindepend
addit
unlik
previou
report
lrp
accept
broad
rang
concentr
lm
lm
obviou
advantag
reduc
sensit
purifi
rt
reaction
use
qiagen
spin
column
dynabead
similarli
use
deoxyguanosin
rt
reaction
rnase
h
digest
advantag
pcr
success
rtth
dna
polymeras
xl
howev
note
perform
detail
optim
anoth
two
system
expand
long
templat
pcr
system
elongas
enzym
mix
former
system
one
use
buffer
contain
mgcl
common
compon
rt
buffer
make
potenti
promis
reconcil
two
buffer
system
inform
addit
buffer
compon
avail
therefor
optim
perform
improv
sometim
even
advers
effect
measur
includ
addit
addit
dmso
betain
tma
oxal
use
phosphorothio
loop
incorpor
primer
howev
oligonucleoid
inhibitor
rtth
dna
polymeras
requir
reproduc
amplif
minimum
concentr
lm
also
found
interfer
lrp
increas
concentr
lm
unlik
rt
requir
primer
long
pcr
less
stringent
long
valu
primer
approxim
optim
protocol
rna
extract
serum
use
qiaamp
viral
rna
mini
kit
qiagen
rna
templat
mix
rt
matrix
consist
superscript
iii
buffer
mm
dtt
lm
revers
primer
mm
dntp
invitrogen
u
rnasein
ribonucleas
inhibitor
u
superscript
iii
u
amv
promega
reaction
perform
incub
min
follow
heat
min
five
microlit
rt
reaction
appli
first
round
pcr
contain
mm
mg
oac
xl
pcr
buffer
mm
dntp
invitrogen
lm
lm
primer
u
rtth
xl
dna
polymeras
cycl
paramet
program
min
follow
first
cycl
min
final
cycl
annealingelong
temperatur
reduc
min
autoextens
cycl
reaction
end
incub
two
microlit
first
round
pcr
product
use
second
round
amplif
primer
cycl
paramet
first
round
pcr
except
annealingelong
temperatur
chang
first
cycl
last
cycl
respect
use
protocol
bp
fragment
reproduc
obtain
sampl
rj
fig
optim
lrp
protocol
test
hcv
genotyp
sampl
serum
plasma
variou
rna
level
rang
iuml
predict
dna
fragment
kb
success
amplifi
sampl
even
low
hcv
rna
level
repres
result
shown
fig
result
indic
lrp
protocol
robust
sensit
sampl
hcv
rna
level
less
iuml
lrp
amplif
improv
extract
total
rna
serum
instead
serum
data
shown
optim
lrp
protocol
use
four
primer
sequenc
align
show
primer
domain
rel
conserv
hcv
genotyp
isol
especi
end
primer
also
found
one
two
nucleotid
substitut
within
primer
abrog
lrp
amplif
result
diminish
amount
amplicon
determin
agaros
gel
electrophoresi
encount
unexpect
difficulti
clone
lrp
product
approxim
kb
length
repeatedli
tri
four
commerci
clone
kit
topo
xl
pcr
clone
kit
copyright
clone
kit
clone
smart
blunt
clone
kit
gateway
technolog
clonas
ii
common
problem
clone
kit
high
background
clone
without
insert
gener
assum
result
either
toxic
foreign
gene
instabl
recombin
clone
sinc
psmart
vector
copyright
clone
smart
blunt
clone
kit
contain
multipl
termin
elimin
transcript
insert
dna
therefor
reduc
potenti
toxic
insert
instabl
recombin
clone
may
respons
high
background
fals
posit
clone
therefor
construct
pclone
vector
contain
pbr
origin
restrict
site
found
hcv
genom
convent
strategi
lrp
product
success
clone
e
coli
cell
cell
posit
rate
recombin
clone
much
higher
previou
report
ml
minicultur
yield
approxim
lg
recombin
clone
suitabl
amount
perform
analysi
sequenc
see
lrp
protocol
preserv
viral
divers
evalu
hcv
quasispeci
base
domain
deriv
either
short
amplicon
kb
lrp
product
sequenc
domain
posit
recombin
clone
sampl
respect
gener
compar
level
genet
complex
genet
divers
except
significantli
higher
genet
complex
amino
acid
level
sampl
versu
p
tabl
sampl
low
genet
divers
similar
quasispeci
lineag
obtain
either
short
fragment
amplif
lrp
fig
howev
compar
quasispeci
profil
respect
deriv
kb
kb
amplicon
sampl
one
lineag
share
amplicon
fig
lrp
perform
use
mixtur
equal
amount
serum
sampl
twenti
clone
deriv
lrp
product
sequenc
eight
domain
includ
utr
core
phylogenet
analysi
show
eight
clone
belong
sampl
clone
neighborjoin
tree
construct
domain
display
consist
cluster
clone
suggest
absenc
potenti
recombin
induc
lrp
repres
tree
construct
hcv
domain
shown
fig
although
sequenc
clone
fulllength
possibl
recombin
small
exclud
sinc
eight
domain
sequenc
evenli
scatter
along
entir
kb
amplicon
long
rtpcr
success
use
amplifi
larg
near
fulllength
domain
rna
virus
includ
human
coronaviru
polioviru
borna
diseas
viru
porcin
reproduct
respiratori
syndrom
viru
coxsackieviru
hepat
e
viru
also
appli
amplif
cellular
rna
deriv
gene
neurofibromatosi
polycyst
kidney
diseas
gene
studi
common
featur
avail
good
rna
templat
quantiti
qualiti
contrast
hcv
easili
cultur
vitro
although
recent
report
establish
hcv
cell
cultur
use
special
hcv
genotyp
strain
clinic
sampl
patient
infect
hcv
rel
low
titer
viral
rna
level
addit
hcv
hold
strong
structur
along
whole
genom
featur
may
explain
limit
success
lrp
hcv
occasion
report
regard
amplif
near
fulllength
hcv
genom
reproduc
result
obtain
amplif
less
kb
fragment
hcv
contrast
protocol
describ
consider
robust
besid
two
serum
sampl
use
optim
protocol
success
amplifi
near
fulllength
hcv
genom
addit
patient
sampl
infect
hcv
genotyp
identifi
sever
critic
factor
effici
amplif
near
fulllength
hcv
genom
first
rt
step
conduct
use
mix
enzym
superscript
iii
amv
superscript
iii
mutant
form
superscript
ii
make
fulli
activ
temperatur
high
potenti
rna
secondari
structur
could
melt
temperatur
howev
incub
result
decreas
sensit
perhap
due
partial
degrad
rna
templat
optim
protocol
use
rt
reaction
report
amv
especi
favor
revers
transcript
gene
gcrich
domain
strong
secondari
structur
due
stabil
higher
temperatur
known
two
enzym
work
togeth
similar
cooper
observ
mix
dna
polymeras
long
pcr
case
demonstr
mix
rt
enzym
improv
fulllength
hcv
cdna
synthesi
qualiti
quantiti
second
primer
effect
prime
synthesi
fulllength
hcv
cdna
experi
one
primer
met
requir
indic
fulllength
hcv
cdna
synthesi
consider
depend
appropri
prime
site
extent
observ
consist
previou
report
differenti
prime
rna
templat
result
obviou
differ
accuraci
reproduc
rtpcr
third
use
pcr
step
recommend
inclus
result
autom
hotstart
pcr
amplif
although
sever
techniqu
avail
initi
hotstart
pcr
manual
control
use
wax
addit
antibodi
thermal
stabl
dna
ploymeras
none
effici
conveni
final
primer
pcr
procedur
appropri
valu
depend
annealingelong
temperatur
last
optim
step
success
lrp
rais
annealingelong
temperatur
second
round
pcr
around
primer
valu
larg
differ
annealingelong
temperatur
primer
valu
result
nonspecif
amplif
low
annealingelong
temperatur
less
alway
abrog
amplif
two
salient
featur
lrp
procedur
lack
detect
recombin
preserv
viral
divers
estim
sampl
recombin
gener
explain
templat
switch
pcr
particularli
synthesi
complementari
strand
stop
prematur
lack
detect
recombin
lrp
protocol
may
contribut
reduc
cycl
number
cycl
versu
regular
cycl
vent
dna
polymeras
includ
within
rtth
dna
polymeras
xl
exonucleas
proofread
activ
locat
end
hcv
domain
variabl
region
along
entir
hcv
genom
compar
genet
paramet
quasispeci
profil
lrp
protocol
preserv
viral
heterogen
also
report
kb
hcv
amplicon
furthermor
similar
quasispeci
lineag
obtain
sampl
sampl
display
much
differ
quasispeci
lineag
deriv
either
kb
kb
amplicon
use
clone
direct
pcr
templat
fail
amplifi
domain
screen
clone
correct
insert
confirm
enzym
digest
minicultur
data
shown
exclud
possibl
loss
potenti
quasispeci
lineag
cultur
due
instabl
recombin
clone
thu
result
emphas
bia
quasispeci
amplif
use
differ
primer
pair
previous
report
still
defect
interf
particl
dip
anoth
factor
taken
account
gener
dip
natur
viral
mutant
larg
delet
genom
seem
gener
phenomenon
virus
includ
hcv
quasispeci
profil
contribut
dip
could
lost
protocol
sinc
gel
purifi
kb
fragment
prior
clone
taken
togeth
quantit
viral
divers
present
high
level
within
given
sampl
larg
underestim
andor
bias
current
protocol
pcr
amplif
clone
technolog
describ
applic
hcv
genotyp
well
rna
virus
gb
viru
c
hiv
dengu
viru
amplif
effici
clone
near
fulllength
viral
genom
possibl
studi
link
mutat
genomewid
scale
link
mutat
common
strategi
exploit
virus
counter
loss
fit
result
point
mutat
immun
andor
drug
target
identif
common
pattern
link
mutat
help
improv
combin
antivir
strategi
addit
lrp
protocol
preserv
hcv
divers
detect
recombin
induc
pcr
characterist
make
possibl
isol
domin
subdomin
minor
viral
variant
within
complex
viru
popul
facilit
approach
revers
genet
initi
step
revers
genet
construct
vector
contain
fulllength
viral
genom
usual
assembl
overlap
pcr
product
repres
viral
consensu
sequenc
howev
consensu
sequenc
artifici
concept
necessarili
domin
viral
variant
result
replic
infecti
clone
consensu
viral
genom
may
occur
may
partial
explain
infecti
hcv
clone
consensu
replic
cell
cultur
one
contrast
exist
multipl
quasispeci
lineag
patient
deriv
patient
fulmin
hepat
immunocompris
statu
patient
result
extrem
homogen
viral
popul
clone
analysi
domain
situat
consensu
viral
sequenc
may
equal
authent
domin
viral
variant
make
infecti
clone
infecti
fig
repres
neighborjoin
nj
tree
construct
base
hcv
domain
clone
deriv
kb
lrp
product
amplifi
use
mix
serum
sampl
expect
clone
cluster
two
group
contradictori
cluster
clone
tree
construct
seven
domain
indic
lack
lrpmediat
recombin
